T10896L |
CSRM617 hydrochloride
|
CSRM617 hydrochloride(787504-88-5 Free base) |
Others
,
Apoptosis
,
Androgen Receptor
|
|
CSRM617 hydrochloride is a selective small-molecule inhibitor of the transcription factor ONECUT2 ( OC2, a master regula... |
T22094 |
JGB1741
|
ILS-JGB-1741 |
Sirtuin
|
|
JGB1741 is a potent and selective inhibitor of SIRT1 with an IC50 of 15 μM. JGB1741 modulates Bax/Bcl2 ratio, cytochrome... |
T16761 |
RK-287107
|
|
PARP
,
Others
|
|
RK-287107 is an effective and specific inhibitor of tankyrase (IC50s: 14.3 and 10.6 nM for tankyrase-1 and tankyrase-2, ... |
T8184 |
Fucosterol
|
|
PARP
,
Endogenous Metabolite
,
PPAR
|
|
Fucosterol is isolated from E. stolonifera with anti-diabetic, anti-adipogenic and anti-cancer activities. It regulates ... |
T9891 |
PARP1-IN-8
|
N-(3-chlorophenyl)-3-(1-oxo-4-phenylphthalazin-2(1H)-yl)propanamide |
PARP
|
|
PARP1-IN-8 is an effective inhibito of PARP1 (IC50 = 97 nM). |
T60019 |
VPC-70063
|
Thiourea, N-[3,5-bis(trifluoromethyl)phenyl]-N'-(phenylmethyl)- |
PARP
,
Apoptosis
,
c-Myc
|
|
VPC-70063 is an inhibitor of c-Myc-MAX. VPC-70063 exhibits Myc-Max transcriptional activity inhibition of 106% with an I... |
T40310 |
PARP/EZH2-IN-1
|
|
|
|
PARP/EZH2-IN-1 is a first-in-class dual PARP ( IC 50 6.87 nM) and EZH2 ( IC 50 36.51 nM) inhibitor for triple-negative b... |
T61798 |
PARP-1-IN-1
|
|
|
|
PARP-1-IN-1 is a high selective and orally active PARP-1 inhibitor ( IC 50 =0.96 nM). PARP-1-IN-1 has well tolerance and... |
T61962 |
PARP-1/HDAC-IN-1
|
|
|
|
PARP-1/HDAC-IN-1 is an effective dual inhibitor of PARP-1/HDAC6, with IC50 of 68.90 nM and 510 nM respectively. PARP-1/H... |
T39139 |
PARP1-IN-6
|
|
|
|
PARP1-IN-6 is a dual tubulin/PARP-1 inhibitor with IC 50 values of 0.94 and 0.48 μM, respectively. |
T35763 |
PARP1-IN-5 dihydrochloride
|
|
|
|
PARP1-IN-5 dihydrochloride is a low toxicity, orally active, potent and selective PARP-1 inhibitor (IC50 =14.7 nM). PARP... |
T24597 |
PARPi-FL
|
Olaparib-bodipy FL , Olaparib bodipy FL |
|
|
PARPi-FL is an agent of fluorescent PARP imaging. In vitro, it is capable of detecting the target engagement of a PARP i... |
T60039 |
KSQ-4279
|
|
|
|
USP1-IN-1 (Formula I) is a USP1 and PARP inhibitor (extracted from patent WO2021163530). |
T36251 |
DP-C-4
|
|
|
|
DP-C-4 is a Cereblon-based dual PROTAC for simultaneous degradation of EGFR and PARP[1].
DP-C-4 (1-50 μM; 24 hours) has ... |
T61335 |
Rucaparib hydrochloride
|
|
|
|
Rucaparib (AG014699) hydrochloride is an orally active, potent inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) wi... |
T61657 |
Rucaparib acetate
|
|
|
|
Rucaparib (AG014699) acetate is an orally active, potent inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) with a K... |
T36304 |
Fluorescein-NAD+
|
|
|
|
Fluoroscein NAD+ is a substrate for ADP-ribosylation, providing a convenient non-isotopic alternative to radiolabelled N... |
T41176 |
PARPYnD
|
|
|
|
PARPYnD is a potent photoaffinity probe for poly(ADP-ribose) polymerase (PARP) (IC50 values for PARP2, PARP1 and PARP6 a... |
T62044 |
Anticancer agent 71
|
|
|
|
Anticancer agent 71 (Compound 4b) is a potent anticancer agent. Anticancer agent 71 arrests cell cycle at G2/M phase. An... |